ARCHIVES

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

This article is from The Cancer Letter archive.

Vol. 06 No. 45 | November 14, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 12, 1974

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

In Brief: CDP Services Wins ASC Planning Contract; Jury Finds Sarin Guilty of Embezzlement

July 17, 1992